Sermorelin peptide is a synthetic GHRH fragment studied in endocrine and growth hormone axis laboratory research.

Sermorelin Peptide

Overview

Sermorelin (also referred to as GRF 1-29) is a synthetic peptide corresponding to the biologically active N-terminal fragment of growth hormone-releasing hormone (GHRH). Current Sermorelin peptide research focuses on receptor-mediated endocrine signaling pathways and GH/IGF-axis communication studied in controlled laboratory and in vitro environments. Research on Sermorelin peptide continues to expand into models evaluating GHRH receptor signaling, peptide stability, and coordinated cellular responses under controlled laboratory conditions. Sermorelin is frequently examined alongside other growth hormone secretagogue research compounds in experimental settings, particularly in models investigating endocrine signaling. This compound is supplied strictly for research and analytical purposes and is not intended for human or veterinary use. Sermorelin peptide is frequently referenced in research literature examining GHRH-associated signaling under controlled laboratory conditions.

Sermorelin Peptide Mechanism of Action (Research Context)

In laboratory studies, Sermorelin has been evaluated for its interaction with GHRH receptor-associated signaling and downstream GH/IGF-axis pathways under controlled experimental conditions. These mechanisms are studied exclusively in experimental environments to better understand peptide-mediated signaling behavior at the molecular level.

Additional Research Considerations

Current investigations continue to assess endocrine signaling, receptor-ligand interaction, and GH/IGF-axis pathway behavior across different in vitro systems and analytical frameworks. Research efforts are also focused on understanding how variations in experimental design, concentration, and molecular stability may affect peptide behavior across different in vitro systems. Further scientific literature related to peptide-based research can be accessed through established databases such as PubMed, where ongoing studies and experimental findings are published.

Research Applications

• Endocrine signaling pathway analysis in controlled in vitro models
• Receptor-ligand interaction studies involving GHRH-associated pathways
• Hormone-related molecular signaling investigations
• GH/IGF-axis-associated pathway characterization at the cellular level
• Peptide structure-function and assay development research

Product Specifications

• Form: Lyophilized powder
• Purity: ≥99% (HPLC)
• Quantity: 10 mg
• Molecular Weight: 3,357.88 Da
• CAS Number: 114466-38-5
• Solubility: Soluble in sterile water or compatible aqueous buffers
• Characterization: HPLC, Mass Spectrometry
• Testing: Third-party verified (COA available)

Storage and Handling

Store at −20 °C (−4 °F) or below. Store in the original vial, sealed and protected from light and moisture until use. Avoid repeated freeze-thaw cycles. Shelf life up to 24 months when stored lyophilized.

Related Research Compounds

Sermorelin is frequently studied alongside other research compounds in laboratory environments.

• Explore CJC-1295 (No DAC)
• View CJC-1295 (DAC)
• Explore Ipamorelin

This compound is part of our Growth Hormone & Secretagogue Research Peptides category, which includes a range of laboratory-grade peptide compounds studied in controlled environments.

Frequently Asked Questions

What is Sermorelin used for in research?

Sermorelin is studied in laboratory environments for its association with GHRH receptor signaling and growth hormone axis research models.

How is Sermorelin studied?

This compound is examined in controlled in vitro research settings, including cellular models and biochemical pathway analysis.

Is this product for human use?

No. This product is strictly for research use only.

Disclaimer, Intended Use & Terms of Sale

All content and information provided are for educational and research reference purposes only. This product and its associated data have not been evaluated by the U.S. Food and Drug Administration, and no claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. No representations or warranties are made regarding safety, effectiveness, or outcomes. This product is intended strictly for in vitro laboratory research use only and is not for clinical use. It is not approved for human or animal administration and must not be used in food, dietary supplements, pharmaceuticals, cosmetics, or any consumer applications. By purchasing from Badger Compounds, the buyer affirms that they are a qualified researcher or institution with the appropriate training and facilities to handle research compounds in compliance with all applicable laws and regulations. All sales are final.